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ENZYMES concerned in the catabolism ofnucleic acids have been little studied
in liver tumours, and especially in tumours which, from careful histological
examination, could be regarded as hepatomas and could, therefore, reasonably
be compared with normal liver. In normal liver the degradation ofadenosine can
proceed by the following pathway (Christman, 1952):
adenosine
adenosine deaminase
inosine
nucleoside phosphorylase
hypoxanthine
xanthine oxidase
xanthine
xanthine oxidase
uric acid
Changes in these enzymes in azo-dye carcinogenesis have now been investigated.
EXPERIMENTAL
The tissue fractions now analyzed were those prepared in a previous study
(Reid and O'Neal, 1956), to which reference should be made for details of the
procedures employed. The fractions were, in general, derived from the livers of
albino rats which had been fed 3'-methyl-4-dimethylaminoazobenzene; but one
experiment (" 14/7") was carried out with a hepatoma arising in a rat of the
"August" strain which had been fed p-dimethylaminophenylazo-2-naphthalene.
As indicated in Fig. 1, experimental rats were always studied simultaneously
with controls which had been fed on the same diet but with omission of the
carcinogen.
The "pre-cancerous liver" studied in some experiments was obtained from
rats which had been fed the azo-dye for only 4 weeks. Tissue from rats which
had been fed azo-dye for a prolonged period was classified into the following
categories, with the kind collaboration of Dr. R. Daoust: hepatoma with little
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FIG. la.-Adenosine deaminase levels, expressed asti moles inosine
decomposed per min. per g. of tissue.
FIG. lb.-Nucleoside phosphorylase levels, expressed as L moles
adenosine decomposed per min. per g. of tissue.
FIG. lc.-Xanthine oxidase levels, expressed as V moles xanthine
decomposed per min. per g. of tissue.
The following abbreviations are used for the different types of liver tissue:
C. Control (open bars).
P, Pre-cancerous (bars with vertical lines).
H, Hepatoma with little necrosis (solid bars). HN, Hepatoma with marked necrosis (bars with stippling). HC, Mixed hepatoma and cholangioma (bars with diagonal hatching). L, Liver tissue without tumours (bars with white squares on block).
Bars in direct apposition represent different tissue samples from the same rat.
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necrosis, hepatoma with marked necrosis, mixed hepatoma and cholangioma, and
liver tissue without tumours (tumours being present elsewhere in the liver). Since
there was liver enlargement after azo-dye feeding, especially if prolonged (Reid
and O'Neal, 1956), any decrease in the amount of an enzyme per g. of liver (cf.
Fig. 1) does not entail a correspondingly great decrease in the total amount of
the enzyme per liver.
As previously described (Reid and O'Neal, 1956), the tissue homogenates
were freed from nuclei by centrifugation to give a cytoplasmic fraction, from a
portion of which a supernatant fraction was derived by a final centrifugation at
20,000 g for 90 minutes. These two fractions were frozen and stored at - 30°
until required for assay, this procedure being without adverse effect on the activity
ofthe enzymes studied.
The enzyme assays wereperformed by differential spectrophotometry (Kalckar,
1947), the activity of each tissue sample being assessed from the rate of change of
extinction (determined graphically) at the appropriate wavelength. Adenosine
deaminase and nucleoside phosphorylase were assayed at 21-22° essentially by
the procedures of Schneider and Hogeboom (1952), as used by Reid and Stevens
(1958) in another connection; the latter enzyme was assayed in the presence of
an excess of purified xanthine oxidase whereby the hypoxanthine (formed from
inosine) was oxidizedtouric acid. Xanthine oxidasewasassayed at 24° as described
by Reid, O'Neal and Lewin (1956); whole cytoplasmic fractions were used,
although most of the cytoplasmic activity is in fact found in the supernatant
fraction. The other enzymes were assayed in supernatant fractions, in which
virtually all the cytoplasmic activity resides (Schneider and Hogeboom, 1952).
RESULTS
As is shown inFig. la, there were no consistent changes in adenosine deaminase
activity. In contrast with adenosine deaminase, nucleoside phosphorylase activity
was notably low in hepatomxnas, this low level being not merely a consequence
of necrosis (Fig. lb). The activity was not markedly depressed in liver tissue
distant from the tumours.
Xanthine oxidase activity in hepatomas showed decreases remarkably similar
to those observed with nucleoside phosphorylase (Fig. lc). The activities of these
two enzymes in some of the hepatomas were less than one-quarter of those in
the controls studied simultaneously. Xanthine-oxidase activity was also somewhat
decreased in pre-cancerous liver.
DISCUSSION
The present findings are in good agreement with observations which were pub-
lished in abstract form by Lamirande and Allard (1957) after the completion of
our work. These authors found that Novikoff hepatoma transplants lacked
xanthine oxidase and uricase, and were deficient in nucleotidase (nucleoside
5'-phosphatase), guanase, and nucleoside phosphorylase; in contrast with these
enzymes, adenosine deaminase was increased. Westerfeld, Richert and Hillinger
(1950) have also reported a marked fall in xanthine oxidase under the "syner-
gistic" influences of 4-dimethylaminoazobenzene and of a low-protein diet;
but with a high-protein diet, as used in the present study, this carcinogen induced
only a small decrease in xanthine oxidase. It may, however, be significant that the
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main pathological change observed in the livers studied by these authors was
bile-duct proliferation, and that the tumours which were eventually obtained
(but not studied biochemically) were ofbile-duct origin. Here it may be noted that
experiments in this Institute (Lewin, Bergel, Bray, Haddow and Lewin, 1957)
have shown a decrease in xanthine oxidase in spontaneous mammary tumours,
similar to that in the hepatomas now studied. Moreover, rabbit liver carcinomas
showed abnormally low oxygen uptake with xanthine as subtrate, although
"xanthine dehydrogenase" (assayed by the use of methylene blue) was undi-
minished (Korotkoruchko, 1953).
The possibility that xanthine oxidase is a "key" enzyme, governing the rate
of purine catabolism, has been discussed by Bergel, Bray, Haddow and Lewin
(1957), and also by Reid and Stevens (1958) who adduced supporting evidence
from hormonal studies (Reid, O'Neal and Lewin, 1956) but who quoted some
contrary evidence. Thus, Bass, Tepperman, Richert and Westerfeld (1950)
found that the fall in liver xanthine oxidase produced by protein deprivation or
by azo-dye feeding was not accompanied by decreases in the excretion of uric
acid and allantoin. Begg (1955) found that when tumour-bearing rats were given
a low-protein diet, the usual fall in liver xanthine oxidase did not occur and the
excretion of allantoin actually increased; but he did not regard it as proven that
the latter effect was a consequence of the former.
In view of the possibility that uricase might be a limiting enzyme in liver
(Reid and Stevens, 1958), it is of interest that a fall in uricase was observed with
the hepatomas studied by Lamirande and Allard (1957) and also, in a single
determination, with liver from a rat fed 3'-methyl-4-dimethylaminoazobenzene
for 28 days (Schneider, Hogeboom, Shelton and Striebich, 1953).
If purine catabolism is indeed decreased in liver tumours, it does not follow
that nucleic-acid catabolism is also decreased. There is some evidence that the
nucleases which effect the initial hydrolysis of nucleic acids to nucleotides are
actually increased in pre-cancerous liver and in primary liver tumours (Allard,
1955; Schneider, Hogeboom, Shelton and Striebich, 1953). The fall in nucleoside
phosphorylase does not imply a decrease in nucleic-acid catabolism, since this
enzyme, of which there is a relatively high level in liver, is probably not a limiting
factor in nucleic-acid catabolism (Reid and Stevens, 1958). The decrease in
nucleoside phosphorylase might in fact imply a decrease in synthetic rather than
in catabolic processes. The level of adenosine deaminase in normal liver is much
lower than that of nucleoside phosphorylase, and would be more likely to reflect
any decrease in nucleic-acid catabolism; however the level ofadenosine deaminase
in hepatomas is normal (as now reported) or even increased (Lamirande and Allard,
1957). There are reports that the level of nucleotidase (nucleoside-2', 3'-phospha-
tase) is normal in hepatomas (Greenstein, Carter and Luthardt, 1946), and that
the level ofapossibly differentnucleotidase (nucleotide 5'-phosphatase) is decreased
(Lamirande and Allard, 1957). The metabolism of nucleic acids and their deriva-
tives in cancerous liver and, indeed, in normal liver clearly warrants further study.
SUMMARY
With hepatomas induced by azo-dye feeding, there are marked decreases in
the concentrations of nucleoside phosphorylase and of xanthine oxidase (the
latter being also somewhat decreased in pre-cancerous liver) but no changes in
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the concentration of adenosine deaminase. These findings are discussed with
particular reference to the hypothesis that xanthine oxidase is a limiting factor in
purine catabolism.
The authors are indebted to Dr. R. C. Bray and to Mr. D. A. Gilbert, B.Sc.,
for providing the purified xanthine oxidase for the determination of nucleoside
phosphorylase, and to Mr. E. Sykes for drawing Fig. 1. Funds for the purchase
of the ultraviolet spectrophotometer were provided (to E. R.) by the British
Empire Cancer Campaign.
REFERENCES
ALLARD, C.-(1955) Canad. Cancer Conf., 1, 319.
BAss, A. D., TEPPERMAN, J., RICHERT, D. A. AND WESTERFELD, W. W.-(1950) Proc.
Soc. exp. Biol., N.Y., 73, 687.
BEGG, R. W.-(1955) Canad. Cancer Conf., 1, 237.
BERGEL, F., BRAY, R. C., HADDOW, A. AND LEWr, I.-(1957) in Chemistry and Biology
of Purines (Ciba Foundation Symposium), ed. Wolstenholme, G. E. W. and
O'Connor, B. M. London (J. and A. Churchill), p. 256.
CHRISTMAN, A. A.-(1952) Physiol. Rev., 32, 303.
GREENSTEIN, J. P., CARTER, C. E. AND LUTHARDT, F. M.-(1946) J. nat. Cancer Inst.,
7, 47.
KALCKAR, H. M.-(1947) J. biol. Chem., 167, 461.
KOROTKORUCHKO, V. P.-(1953) Biokhem. Zh., 25, 173.
DE LAMIRANDE, G. AND ALLARD, C.-(1957) Proc. Amer. Ass. Cancer Res., 2, 224.
LEWIN, I., BERGEL, F., BRAY, R. C., HADDOW, A. AND LEWIN, I.-(1957) Ibid., 2, 226.
REID, E. AND O'NEAL, M. A.-(1956) Brit. J. Cancer, 10, 587.
Iidem AND LEwN, I.-(1956) Biochem. J., 64, 730.
Idem AND STEVENS, B. M.-(1958) Ibid., in press.
SCHNEIDER, W. C. AND HOGEBOOM, G. H.-(1952) J. biol. Chem., 195, 161.
Iidem, SHELTON, E. AND STRIEBICH, M. J.-(1953) Cancer Res., 13, 285.
WESTWEFELD, W. W., RICHERT, D. A. AND HILLINGER, M. F.-(1950) Ibid., 10, 486.